BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29

• Biotech Bay

  California Life Sciences Association Thanks Senator Bill Monning and Assemblymember Katcho Achadjian for Raising Awareness of Rare Diseases

  February 25, 2016

   · 

  2 min read
• Drug Development

  ViiV Healthcare Announces First Phase II HIV Prevention Study Results for Investigational Long-acting Injectable Cabotegravir

  February 25, 2016

   · 

  6 min read
• Drug Development

  Rigel Initiates Phase 2 Clinical Trial Of Fostamatinib In Autoimmune Hemolytic Anemia

  February 25, 2016

   · 

  4 min read
• Drug Development

  Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Analysis Confirms OFEV (nintedanib) Slows Disease Progression In IPF And Reduces Risk Of Acute Exacerbations

  February 25, 2016

   · 

  8 min read
• Policy

  XYMOGEN Earns Prestigious Australian TGA Certification

  February 25, 2016

   · 

  2 min read
• Business

  Immune Pharma Names Dr. Jeff Paley To Its Board Of Directors

  February 25, 2016

   · 

  5 min read
• Biotech Beach

  Aethlon Medical’s Exosome Sciences Announces The Publication Of Preliminary Findings Of A Blood Test To Detect Chronic Traumatic Encephalopathy (CTE) During Life

  February 25, 2016

   · 

  7 min read
• Policy

  Firstkind, A Sky Medical Technology Company, Is Delighted To Announce RCN Accreditation Of Its User Training Programme For The geko Device For VTE Prevention

  February 25, 2016

   · 

  2 min read
• Business

  Propeller Partners With Global Drug Delivery Systems Provider Aptar Pharma For Development Of A Next-Generation, Integrated, Connected Metered Dose Inhaler

  February 25, 2016

   · 

  4 min read
• Drug Development

  Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) And UAB Expand Their Research To Two New Gene Therapies For Sanfilippo B Syndrome And Hunter Syndrome

  February 25, 2016

   · 

  2 min read